Hinweis-Modus ist eingeschaltet Ausschalten

Replimune Group: And In The Accompanying Exhibit 99.1 Shall Not Be Incorporated By Reference Into Any Filing Of The Company, Whether Made Before Or After The Date Hereof, Regardless Of Any General Incorporation Language In Such Filing, Unless Expressly Incorporated By Specific Reference To Such Filing. The Information In This Item 7.01 And The Accompanying Exhibit 99.1 Shall Not Be Deemed To Be “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended, Or Otherwise Subject To The Liabilities Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended, Financial Statements And Exhibits

Den gesamten Artikel anzeigen
Diese Funktion ist nur für autorisierte Benutzer verfügbar
Emittent — Replimune Group
  • Vollständiger Name
    Replimune Group, Inc.
  • Eintragungsland
    USA
  • Branche
    Pharmaceutical Preparation and Biotechnology
  • М/S&P/F
    *** / *** / ***
Sie müssen sich registrieren , um Zugriff zu erhalten.